Century Therapeutics, Inc.IPSCNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank83
3Y CAGR-63.4%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
-63.4%/yr
Annual compound
Percentile
P83
Within normal range
vs 3Y Ago
0x
Contraction
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 5.68% |
| 2024 | -24.66% |
| 2023 | -728.72% |
| 2022 | 115.79% |
| 2021 | -115.66% |
| 2020 | -155.25% |
| 2019 | 0.00% |